Utilization of Bioprocess Materials and Life Sciences Collaboration through a Capital and Business Alliance with JSR
First written in FY2017-Q3. 3 of 4 entries say "Restated". Latest entry: FY2019.
No other company in this theme has enough history to compare yet.
- FY2019RestatedAnnual report
「In April 2018, NanoCarrier Co., Ltd., which owns micellar nanoparticle technology, an advanced nanotechnology originating in Japan, entered into a capital and business alliance agreement with Noritsu Koki Co., Ltd., its parent company, and us. The three companies began drug discovery activities under a collaborative framework aimed at creating innovative technologies and pharmaceuticals by combining their respective technologies and expertise.」
We continue drug discovery activities conducted jointly by NanoCarrier, Noritsu Koki and the company. - FY2018RestatedAnnual report
「In December 2016, we formed a capital and business alliance with JSR Co., Ltd., which focuses on the life sciences business, including the development and manufacture of bioprocess materials and other products important to biopharmaceutical manufacturing.」
We continue the capital and business alliance with JSR and collaboration in the life sciences field, including bioprocess materials technology. - FY2017RestatedAnnual report
「In December 2016, we formed a capital and business alliance with JSR Co., Ltd., which focuses on the life sciences business, including the development and manufacture of bioprocess materials and other products important to biopharmaceutical manufacturing.」
We continue the capital and business alliance with JSR and collaboration in the life sciences field, including bioprocess materials technology. - FY2017-Q3First statedAnnual report
「In addition, we entered into a capital and business alliance agreement with JSR Co., Ltd. in December of that year and will consider collaboration from time to time in the life sciences business, including the utilization of its technology relating to bioprocess materials.」
The capital and business alliance with JSR marked the first appearance of a theme involving future consideration of collaboration in the life sciences business, including the utilization of JSR's bioprocess materials technology.